R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
AXIAL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
04/10/2024
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
09/28/2020
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/01/2022
First use in commerce
10/01/2022
Drawing code
3
Owner type
03
Owner location
WOBURN, MA
Examiner
MASON,JARED MICHAEL
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of eight circles, each connected to a central donut circle by two horizontal lines at the left and right, one shorter vertical line at the top, one longer vertical line at the bottom, one short diagonal line at the lower-left, one longer diagonal line at the upper-left, one slightly longer diagonal line at the upper-right, and one longer diagonal line at the lower right. To the right of this is the stacked stylized wording "AXIAL THERAPEUTICS" where "AXIAL" is in larger-sized font and "THERAPEUTICS" is in smaller-sized font.
Holders and representatives
Holders
AXIAL THERAPEUTICS, INC.
Axial Biotherapeutics, Inc.
Representatives
Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalsbiochemicalscellsmicrobes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparationsfor in vitro and in vivo scientific or research usefor use in industry and science; chemicalbiochemical and microbial productsone or more of small moleculesproteinsantibodiesnucleic acidsprobiotic bacteriaprobiotic bacterial culturesmicrobes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatmentpreventiondetection of central nervous system diseases and disorderscancertumorsfibrosisinflammationmicrobe-related and microbiome-related conditionsgastrointestinal and immunological diseasesany disease or disorder associated with intestinal permeabilityleaky gutamyloids
Class 5
Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatmentpreventiondetection of central nervous system diseases and disorderscancertumorsfibrosisinflammationmicrobe-related and microbiome-related conditionsgastrointestinal and immunological diseasesany disease or disorder associated with intestinal permeabilityleaky gutamyloids; chemicalbiochemical and microbial productsone or more of small moleculesproteinsantibodiesnucleic acidsprobiotic bacteriaprobiotic bacterial culturesmicrobes being pharmaceutical preparations and substances for the treatmentpreventiondetection of central nervous system diseases and disorderscancertumorsfibrosisinflammationmicrobe-related and microbiome-related conditionsgastrointestinal and immunological diseasesany disease or disorder associated with intestinal permeabilityleaky gutamyloids
Class 42
Providing medical and scientific research information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistrybiotechnologyconducting clinical trials for others
Class 44
Providing medical information in the fields of diagnosticprophylactictherapeutic properties of probiotic or microbe-targeted pharmaceuticals
Publications
History of USPTO decisions and trademark events.
45 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/07/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2024
ALIE
ASSIGNED TO LIE
02/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/18/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/21/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/21/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2023
GNRT
NON-FINAL ACTION E-MAILED
04/04/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/04/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/06/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/06/2023
IUAF
USE AMENDMENT FILED
02/17/2023
EISU
TEAS STATEMENT OF USE RECEIVED
02/17/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/13/2023
EX2G
SOU EXTENSION 2 GRANTED
01/11/2023
EXT2
SOU EXTENSION 2 FILED
01/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/21/2022
EX1G
SOU EXTENSION 1 GRANTED
06/17/2022
EXT1
SOU EXTENSION 1 FILED
06/17/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/17/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/17/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/24/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2021
GNRT
NON-FINAL ACTION E-MAILED
03/22/2021
CNRT
NON-FINAL ACTION WRITTEN
03/22/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/25/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/25/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/25/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/25/2021
DOCK
ASSIGNED TO EXAMINER
02/19/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2020
NWAP
NEW APPLICATION ENTERED
10/01/2020
Continuous trademark protection
Get notified about every new filing that threatens AXIAL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.